| Healthy Subjects n = 30 | BAV- native n = 30 | AVR-mechanical n = 11 | AVR-tissue n = 10 | Ross n = 9 | ANOVA |
---|---|---|---|---|---|---|
Age in years | 43 ± 17 | 42 ± 16 | 42 ± 12 | 58 ± 11 | 24 ± 12 | p < 0.001 |
Systolic flow angle (°) | 7.5 ± 5.3 | 25.6 ± 13.3* | 16.5 ± 9.6 | 16.2 ± 8.5 | 9.8 ± 4.9†| p < 0.001 |
Normalised flow displacement | 0.038 ± 0.036 | 0.133 ± 0.072* | 0.083 ± 0.076 | 0.163 ± 0.064* | 0.096 ± 0.067 | p < 0.001 |
Absolute rotational flow (mm2/ms) | 3.8 ± 3.1 | 26.6 ± 16.6* | 7.2 ± 3.9†| 20.7 ± 8.8* | 10.6 ± 10.5†| p < 0.001 |
Mean systolic WSScircavg (N/m2) | 0.58 ± 0.15 | 0.77 ± 0.23* | 0.67 ± 0.20 | 0.68 ± 0.20 | 0.80 ± 0.35 | p = 0.012 |
Absolute systolic in-plane (rotational) WSS (N/m2) | 0.07 ± 0.06 | 0.40 ± 0.28* | 0.19 ± 0.13†| 0.38 ± 0.19* | 0.21 ± 0.17 | p < 0.001 |
Max systolic through-plane WSS (N/m2) | 0.76 ± 0.21 | 0.95 ± 0.44 | 0.91 ± 0.38 | 0.78 ± 0.215 | 1.03 ± 0.65 | p = 0.206 |
RA-LP systolic WSScircavg (N/m2) | −0.12 ± 0.13 | 0.22 ± 0.31* | 0.27 ± 0.22* | 0.36 ± 0.26* | 0.24 ± 0.67 | p < 0.001 |
Peak velocity (m/s) | – | 2.3 ± 0.8 | 2.1 ± 0.5 | 2.1 ± 0.3 | 1.9 ± 0.8 | p = 0.387 |
Ascending aortic diameter (mm) | 28.6 ± 4.3 | 35.0 ± 6.7* | 35.9 ± 4.4* | 37.9 ± 5.2* | 30.4 ± 8.3 | p < 0.001 |
Diameter at sino-tubuar junction (mm) | 27.9 ± 3.6 | 32.4 ± 6.4* | 31.7 ± 7.8 | 32.9 ± 3.3 | 31.0 ± 6.0 | p = 0.003 |
Diameter at sinuses (mm) | 30.8 ± 3.5 | 32.9 ± 5.8 | 34.1 ± 6.7 (pre-AVR) | 32.1 ± 2.3 (pre-AVR) | 35.9 ± 5.7 | p = 0.068 |
Aortic regurgitant fraction (%) | – | 8.8 ± 9.9 | 3.7 ± 2.8 | 5.8 ± 7.5 | 22.8 ± 20.6†| p = 0.002 |
Left ventricular ejection fraction (%) | – | 68 ± 6 | 67 ± 15 | 70 ± 8 | 65 ± 10 | p = 0.687 |